- About Us
-
Our Business
-
- Therapeutic Areas Our portfolio is diverse and based upon - Market Research, Regulatory & IP.
- Licensing Licensing activities are excellent opportunities for companies to expand their portfolio.
- Biosimilar Biosimilar are biologic medicines that are developed to match their reference medicine.
-
- CRAM India has grown to be one of the key nations complying GMP manufacturing norms.
- Medical Devices REVA help our clients to deliver customized, cost-effective medical device value chain.
-
API
-
Dosage form
-
-
Operations
- At Reva, we have requisite infrastructure, with a balanced reach across Regulated, Emerging & Expansion markets. And we are committed to helping create healthier communities worldwide through education, outreach and better access to treatment.
-
Research & Development
-
Manufacturing
-
Quality
- Media
- Contact us
AMBASSADORS MEET -- "ADVANTAGE INDIA-HEALTHCARE" | 13 April, 2016
AMBASSADORS’ MEET Venue: ITC Maurya, New Delhi
The meet was organized by Pharmexcil {Ministry of Commerce & Industry -- Government of India} to build upon IPHEX-2016. The event is in its 4th year and becomes the largest Pharma & Healthcare Forum for the Indian Industry.
The event has participation of over 500 overseas business delegates from 110 countries. The summit show focuses:
- Buyer-Sellers Interaction
- Regulatory Compliance Seminars
- Interaction with overseas Journalists & Media
- Display of Medical, Nutraceutical & Healthcare Products
The reception evening had a gathering of over 150 destinguished personalities from Diplomats, Government Officals & Industry (Heathcare & Pharma). Their was participation from 35 countries with diplomats assuring interest for the Indian Generic (Medicine).
Dr. Sandhu Honorary Advisor {Pharmexcil} & Managing Director (Reva Pharma) conducted a lecture on: INDIA POSITION & COMPETENCE IN PHARMA. The vision outlined was building business in the Emerging Markets with special emphasis on "Infectious Diseases".